Shareholder alert: weiss law investigates metacrine, inc.

New york , nov. 23, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of metacrine, inc. ("metacrine" or the "company") (nasdaq: mtcr), in connection with the acquisition of the company by equillium, inc. ("equillium") (nasdaq: eq). under the terms of the merger agreement, equillium will issue stock valued at a 25% premium over the net cash delivered at closing, which is estimated to be approximately $26 million.
EQ Ratings Summary
EQ Quant Ranking